<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04907942</url>
  </required_header>
  <id_info>
    <org_study_id>DL-FACE-101</org_study_id>
    <nct_id>NCT04907942</nct_id>
  </id_info>
  <brief_title>Feasibility and Acceptability of Click's EMA and Text Message Intervention for STRESS Management</brief_title>
  <acronym>FACE Stress</acronym>
  <official_title>Feasibility and Acceptability of Click's Ecological Momentary Assessment (EMA) and Text Message Intervention for STRESS Management (FACE STRESS Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Click Therapeutics, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Click Therapeutics, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate feasibility and acceptability of an Ecological&#xD;
      Momentary Assessment (EMA) compared with an EMA plus automated text message intervention for&#xD;
      stress management in participants with higher-than-average perceived stress conducted in a&#xD;
      remote setting.&#xD;
&#xD;
      Study details include:&#xD;
&#xD;
      Study Duration: 7 months Intervention Duration: 3 weeks&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 29, 2020</start_date>
  <completion_date type="Actual">June 20, 2021</completion_date>
  <primary_completion_date type="Actual">December 18, 2020</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The main outcome of the FACE STRESS study is to evaluate feasibility of an EMA and EMA plus text message intervention (EMA+).</measure>
    <time_frame>1 Month</time_frame>
    <description>Feasibility assessed as the proportion of individuals who contacted us because they are interested in participating</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The main outcome of the FACE STRESS study is to evaluate feasibility of an EMA and EMA plus text message intervention (EMA+).</measure>
    <time_frame>1 Month</time_frame>
    <description>Feasibility assessed by the number of eligible individuals after the initial screening</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The main outcome of the FACE STRESS study is to evaluate feasibility of an EMA and EMA plus text message intervention (EMA+).</measure>
    <time_frame>1 Month</time_frame>
    <description>Feasibility assessed by the time taken to recruit the sample</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The main outcome of the FACE STRESS study is to evaluate feasibility of an EMA and EMA plus text message intervention (EMA+).</measure>
    <time_frame>1 Month</time_frame>
    <description>Feasibility assessed by calculating the retention rates</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The main outcome of the FACE STRESS study is to evaluate feasibility of an EMA and EMA plus text message intervention (EMA+).</measure>
    <time_frame>1 Month</time_frame>
    <description>Feasibility assessed by the number of participants responding to any EMA text over the 3-week study</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The main outcome of the FACE STRESS study is to evaluate acceptability of an EMA and EMA plus text message intervention (EMA+).</measure>
    <time_frame>1 Month</time_frame>
    <description>Acceptability (satisfaction/utility) by using open-ended questions/patient interviews</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The main outcome of the FACE STRESS study is to evaluate acceptability of an EMA and EMA plus text message intervention (EMA+).</measure>
    <time_frame>1 Month</time_frame>
    <description>Acceptability assessed by Likert-scales</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ecological Momentary Change in Affects</measure>
    <time_frame>3 Weeks</time_frame>
    <description>Changes in Momentary Affects will be measured by using Ecological Momentary Assessments delivered twice a day for 3 weeks.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Perceived Stress</measure>
    <time_frame>7 Months</time_frame>
    <description>Changes in perceived stress will be measured by using the Perceived Stress Scale at Baseline, 3 weeks post-intervention, and at 1/3/6 month follow-up.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptoms of Anxiety</measure>
    <time_frame>7 Months</time_frame>
    <description>Symptoms of Anxiety will be measured by using the Generalized Anxiety Disorder-7 item scale (GAD-7) at Baseline, 3 weeks post-intervention, and at 1/3/6 month follow-up.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptoms of Depression</measure>
    <time_frame>7 Months</time_frame>
    <description>Change in depression will be measured by using the Patient Health Questionnaire (PHQ-9) at Baseline, 3 weeks post-intervention, and at 1/3/6 month follow-up.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptoms of PTSD</measure>
    <time_frame>7 Months</time_frame>
    <description>Changes in PTSD will be measured by using the Primary Care PTSD Screen for DSM-5 (PC-PTSD-5) at Baseline, 3 weeks post-intervention, and at 1/3/6 month follow-up.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Resilience</measure>
    <time_frame>7 Months</time_frame>
    <description>Changes in resilience will be measured by using the Brief Resilience Scale (BRS) at Baseline, 3 weeks post-intervention, and at 1/3/6 month follow-up.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychological Well-being</measure>
    <time_frame>7 Months</time_frame>
    <description>Changes in psychological well-being will be measured by using the Euthymia Scale at Baseline, 3 weeks post-intervention, and at 1/3/6 month follow-up.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Loneliness</measure>
    <time_frame>7 Months</time_frame>
    <description>Changes in perceived loneliness will be measured by a single question (item) at Baseline, 3 weeks post-intervention, and at 1/3/6 month follow-up.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-Mastery</measure>
    <time_frame>7 Months</time_frame>
    <description>Changes in self-mastery will be measured by using the Pearlin Self-Mastery Scale at Baseline, 3 weeks post-intervention, and at 1/3/6 month follow-up.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">82</enrollment>
  <condition>Stress, Psychological</condition>
  <condition>Loneliness</condition>
  <condition>Covid19</condition>
  <condition>Stress</condition>
  <arm_group>
    <arm_group_label>EMA Alone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>3 weeks of EMA, consisting of 2 surveys per day delivered via text message and email during waking hours to prompt participants to complete the survey.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EMA + Automated Text Message Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 week of EMA, consisting of 2 surveys per day delivered via text message and email during waking hours to prompt participants to complete the survey followed by&#xD;
2 additional weeks of EMA in combination with 2 text messages per day with content related to stress management techniques.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EMA + Automated Text Message Intervention</intervention_name>
    <description>Intervention includes 3 weeks of EMA (2 daily surveys per day delivered during waking hours to evaluate momentary affects) plus 2 weeks of automated text messages delivered twice a day, which content follows constructs from The Transactional Model of Stress and Coping.</description>
    <arm_group_label>EMA + Automated Text Message Intervention</arm_group_label>
    <other_name>Ecological Momentary Assessments</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>EMA Alone</intervention_name>
    <description>Three weeks of EMA consisting of 2 daily surveys per day delivered during waking hours to evaluate momentary affects.</description>
    <arm_group_label>EMA Alone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age 22 years or older&#xD;
&#xD;
          2. Must reside in an Eastern Standard Time or Central Standard Time zone&#xD;
&#xD;
          3. Able to read and write in English as demonstrated by review and completion of an&#xD;
             Informed Consent Form&#xD;
&#xD;
          4. Own an SMS enabled smartphone&#xD;
&#xD;
          5. Scoring &gt;5 on the 4-item Perceived Stress Scale (reflecting higher-than-average&#xD;
             perceived stress)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Reported cognitive impairment and/or psychiatric disorders of the psychotic spectrum&#xD;
&#xD;
          2. Enrolled in another support study&#xD;
&#xD;
          3. Currently receiving psychotherapy through telehealth&#xD;
&#xD;
          4. PHQ-9 score of 20 or greater.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Click Therapeutics</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10013</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>April 2, 2021</study_first_submitted>
  <study_first_submitted_qc>May 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 1, 2021</study_first_posted>
  <last_update_submitted>July 26, 2021</last_update_submitted>
  <last_update_submitted_qc>July 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Stress</keyword>
  <keyword>Anxiety</keyword>
  <keyword>Ecological Momentary Assessment</keyword>
  <keyword>Automated Text Message Intervention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stress, Psychological</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

